Eric Bjerkholt - CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Eric Bjerkholt in Mirum Pharmaceuticals, Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-35,705
Avg price
$99.76
Total value
-$3,562,101

Net

Past year
Shares
-35,705
Share %
-100%
Total value
-$3,562,101

Reported holdings for Eric Bjerkholt in Mirum Pharmaceuticals, Inc.

Form 4 holding CHIEF FINANCIAL OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$255,581
Report date
11 Sep 2026
Price
$47.92
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF FINANCIAL OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
26,653
Estimated value
Report date
09 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF FINANCIAL OFFICER

Mirum Pharmaceuticals, Inc.

Security class
Performance Restricted Stock Units
Shares / value
6,666
Estimated value
Report date
15 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Eric Bjerkholt in Mirum Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .